What is driving Intuitive Surgical's revenue growth?

Revenue growth is primarily driven by the increasing adoption of the da Vinci Surgical System across various surgical specialties, particularly in urology (like prostatectomies) and gynecology (like hysterectomies). This adoption leads to higher sales of the surgical systems themselves, as well as recurring revenue from instruments, accessories, and service contracts associated with system usage.

What is the significance of the increase in recurring revenue?

The substantial increase in recurring revenue, which now constitutes 47% of total revenue, is a positive indicator for the company's business model. It suggests that as more da Vinci systems are installed, the company benefits from a consistent and growing stream of revenue from disposables (instruments and accessories) and services. This recurring revenue is generally higher margin and less capital-intensive than system sales, contributing to improved profitability and predictability.

Are there any significant financial risks or concerns mentioned in the filing?

The primary financial risk highlighted relates to the company's investment portfolio, specifically $89.1 million in Auction Rate Securities (ARS). These securities experienced auction failures starting in February 2008, rendering them illiquid. While the company believes the underlying assets are government-backed and the decline in value is temporary, there is a risk of impairment if auctions continue to fail or credit ratings deteriorate. However, the company states that the lack of liquidity from these investments is not expected to impact its ability to execute its business plan due to strong operating cash flows.

How is Intuitive Surgical managing its investments and cash?

Intuitive Surgical maintains a significant balance of cash, cash equivalents, and investments, totaling $739.8 million as of June 30, 2008. The company invests these funds in a variety of securities including U.S. treasuries, government agencies, corporate debt, money market funds, commercial paper, and municipal bonds. While seeking to preserve principal and maximize income, the company acknowledges the market and interest rate risks associated with these investments, particularly the illiquidity of Auction Rate Securities.

ISRG 10-Q Quarterly Report Q2 FY2008 — Revenue, Net Income, EPS

Summary

Intuitive Surgical, Inc. (ISRG) demonstrated robust financial performance in the second quarter and first half of 2008, with significant year-over-year growth across key metrics. Total revenue surged by 56% in Q2 2008 to $219.2 million and by 60% in the first half to $407.4 million, driven by strong adoption of the da Vinci Surgical System. Recurring revenue, comprising instruments, accessories, and services, also grew substantially, now accounting for 47% of total revenue and indicating a healthy, sustainable business model. The company's installed base of da Vinci Surgical Systems expanded to 946 units by June 30, 2008, fueling increased procedure volumes and subsequent recurring revenue. Profitability improved significantly, with operating income growing by 74% in Q2 2008 to $78.2 million. The company also maintained a strong liquidity position, with cash, cash equivalents, and investments increasing to $739.8 million, providing ample financial flexibility for ongoing operations and strategic investments.

Financial Highlights

26 data points

Beta

Revenue

$219.19M

0.7% Gross Margin

Net Income

$51.18M

0.2% Net Margin

EPS (Diluted)

$0.14

Cash & Equivalents

$223.02M

Free Cash Flow

$104.19M

Financial Statements

Beta

Revenue	$219.19M
Cost of Revenue	$63.13M
Gross Profit	$156.06M
R&D Expenses	$20.36M
SG&A Expenses	$57.50M
Operating Expenses	$77.86M
Operating Income	$78.19M
Net Income	$51.18M
EPS (Basic)	$0.15
EPS (Diluted)	$0.14
Shares Outstanding (Basic)	348.96M
Shares Outstanding (Diluted)	359.82M

Key Highlights

1Total revenue increased by 56% to $219.2 million in Q2 2008 and by 60% to $407.4 million in the first half of 2008.
2Recurring revenue grew by 56% in Q2 2008 to $103.0 million, representing 47% of total revenue.
3Instrument and accessory revenue increased by 61% in Q2 2008, reflecting higher procedure volumes.
485 da Vinci Surgical Systems were sold in Q2 2008, a 52% increase year-over-year, expanding the installed base to 946 systems.
5Operating income increased by 74% to $78.2 million in Q2 2008, with operating margin improving to 36% of revenue.
6Cash, cash equivalents, and investments totaled $739.8 million as of June 30, 2008, demonstrating strong liquidity.
7Net income grew by 67% in Q2 2008 to $51.2 million, with diluted EPS rising to $1.28.

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2008

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions